Intra-operative quality control of coronary artery bypass grafting
Recruiting
- Conditions
- I25Chronic ischaemic heart disease
- Registration Number
- DRKS00016069
- Lead Sponsor
- niversitäts-Herzzentrum Freiburg-Bad KrozingenKlinik für Herz- und Gefäßchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients before planned coronary bypass surgery
- Age greater than and equal to 18 years
- Patient able to explain
Exclusion Criteria
- Renal insufficiency (crea > 1.5 mg/dl; requiring dialysis but possible without excretion of residual urine)
- pregnancy
- Emergency surgery
- Known contrast agent allergy or intolerance
- Hyperthreosis
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Frequency of early graft failure and anastomotic stenoses<br>- Frequency of re-interventions<br>- Correlation of the results with the flow measurement
- Secondary Outcome Measures
Name Time Method - Frequency of postoperative renal insufficiency or need for dialysis (retention parameters: creatinine + urea) and diuresis: day 1, 3, 5, discharge, day 30)<br>- Thyroid parameters (T3, T4, TSH: day 1, 3, 5, discharge, day 30)<br>- CK and CK-MB (day 1, 3, 5, discharge, day 30)<br>- Frequency of lethality by day 30<br>- temporal duration of coronary angiography
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chronic ischaemic heart disease in DRKS00016069 observational study?
How does intra-operative quality control compare to standard-of-care outcomes in coronary artery bypass grafting?
What biomarkers are associated with successful coronary artery bypass grafting outcomes in I25 patients?
What adverse events are reported in observational studies of coronary artery bypass grafting quality control?
Are there combination therapies or alternative approaches to managing chronic ischaemic heart disease alongside intra-operative monitoring?